Efficient gene transfer into the mouse lung by fetal intratracheal injection of rAAV2/6.2
- PMID: 20664525
- PMCID: PMC2997580
- DOI: 10.1038/mt.2010.153
Efficient gene transfer into the mouse lung by fetal intratracheal injection of rAAV2/6.2
Abstract
Fetal gene therapy is one of the possible new therapeutic strategies for congenital or perinatal diseases with high mortality or morbidity. We developed a novel delivery strategy to inject directly into the fetal mouse trachea. Intratracheal (i.t.) injection at embryonic day 18 (E18) was more efficient in targeting the fetal lung than conventional intra-amniotic (i.a.) delivery. Viral vectors derived from adeno-associated virus serotype 6.2, with tropism for the airway epithelium and not earlier tested in the fetal mouse lung, were injected into the fetal trachea. Bioluminescence (BL) imaging (BLI) was combined with magnetic resonance (MR) imaging (MRI) for noninvasive and accurate localization of transgene expression in vivo. Histological analysis for β-galactosidase (β-gal) revealed 17.5% of epithelial cells transduced in the conducting airways and 1.5% in the alveolar cells. Stable gene expression was observed up to 1 month after injection. This study demonstrates that direct injection of rAAV2/6.2 in the fetal mouse trachea is superior to i.a. delivery for transducing the lung. Second, as stable gene transfer was detected up to 1 postnatal month, this approach may be useful to evaluate fetal gene therapy for pulmonary diseases such as cystic fibrosis, requiring both substantial numbers of transduced cells as well as prolonged gene expression to obtain a stable phenotypic effect.
Figures





References
-
- Scotet V, Duguépéroux I, Audrézet MP, Blayau M, Boisseau P, Journel H, et al. Prenatal diagnosis of cystic fibrosis: the 18-year experience of Brittany (western France) Prenat Diagn. 2008;28:197–202. - PubMed
-
- Coutelle C, Themis M, Waddington SN, Buckley SM, Gregory LG, Nivsarkar MS, et al. Gene therapy progress and prospects: fetal gene therapy–first proofs of concept–some adverse effects. Gene Ther. 2005;12:1601–1607. - PubMed
-
- Buckley SM, Waddington SN, Jezzard S, Lawrence L, Schneider H, Holder MV, et al. Factors influencing adenovirus-mediated airway transduction in fetal mice. Mol Ther. 2005;12:484–492. - PubMed
-
- Waddington SN, Nivsarkar MS, Mistry AR, Buckley SM, Kemball-Cook G, Mosley KL, et al. Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood. 2004;104:2714–2721. - PubMed
-
- Waddington SN, Mitrophanous KA, Ellard FM, Buckley SM, Nivsarkar M, Lawrence L, et al. Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice. Gene Ther. 2003;10:1234–1240. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources